Shaping the Future of AI Medical Devices: A Symposium on the Regulation of AI in Health Care and its Policy Implications

Description

Artificial intelligence (AI) is making significant strides in the health care industry, with AI-enhanced medical devices playing an increasingly important role in diagnosis, treatment, and patient care. With more than 690 FDA-approved AI medical devices available, the use of AI in health care presents unique regulatory challenges that require careful consideration.

This symposium, co-hosted by the Johns Hopkins Carey Business School and Johns Hopkins School of Medicine, will explore lessons from this relatively short regulatory history, what remains to be understood from a regulatory science perspective, challenges in the use of AI in clinical care, and implications for future innovation and policymaking.